Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05743127 · ClinicalTrials.gov registry record · NA
3D-Printed Versus Laboratory-Fabricated Hyrax Expanders
A NA study of Maxillary Expansion, sponsored by Ildeu Andrade Jr..
- Recruiting
- Registry status
- NA
- Development phase
- 42
- Enrollment target
- 2
- Study locations
NCT05743127: Recruiting NA study of Maxillary Expansion, sponsored by Ildeu Andrade Jr..
NCT05743127 is a NA study of Maxillary Expansion that is actively recruiting participants, run by Ildeu Andrade Jr.. The registered enrollment target is 42 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05743127, a NA study of Maxillary Expansion, is actively recruiting participants, sponsored by Ildeu Andrade Jr..
- RECRUITING
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
- 2
- Study locations
Study Summary
Maxillary expanders are orthodontic appliances that are commonly used to expand the upper jaw. The purpose of this study will be to compare the effects produced by two different maxillary expanders in children 8-13 years old. The first type of expander is made by hand in an orthodontic laboratory, and the second type of expander is designed on a computer and printed using 3D printers. Both expanders are already used in the MUSC Orthodontics Clinic. The purpose of this study is to see if the 3D printed expander is as effective as the traditional expander made by hand in the laboratory, with more comfort to the patient. Patients participating in the study will be randomly assigned to one of two groups: group A will be treated with a laboratory-made maxillary expander, and group B with a 3D-Printed maxillary expander. Information will be collected on the participants' standard clinical follow-up visits including photos, x-rays, and dental photo scans over the course of 6 months to see how the expander is working. In addition, as part of the research study, the participant will be asked to complete online questionnaires with assistance from parents or guardians about his/her quality of life and perception of possible pain and discomfort at different time points. The potential benefits of this study include the use of 3D technology to improve the quality of the orthodontic treatment, with more comfort to the patient.
Primary Outcome
The dimension of the anterior midpalatal suture opening between the maxillary halves will be measured digitally in millimeters on the occlusal radiograph using a calibrated ruler.
Conditions Studied
Interventions
- DEVICE 3D-Printed Hyrax Expander
- DEVICE Conventional Laboratory Fabricated Hyrax Expander
Study Locations (2)
Pennsylvania
- University of Pittsburgh - School of Dental Medicine - Pittsburgh
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2023-02-15 |
| Est. Completion | 2027-05-01 |
| Phase | NA |
What NCT05743127 shows while recruiting
NCT05743127 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Maxillary Expansion appearing as the primary indexed condition, and to 2 interventions - of which 3D-Printed Hyrax Expander is the first listed.
NCT05743127 reports a single indexed study location in Pennsylvania, South Carolina.
Frequently Asked Questions
What is clinical trial NCT05743127 about?
NCT05743127 is a clinical study titled "3D-Printed Versus Laboratory-Fabricated Hyrax Expanders". Maxillary expanders are orthodontic appliances that are commonly used to expand the upper jaw. The purpose of this study will be to compare the effects produced by two different maxillary expanders in children 8-13 years old. The first type of expander is made by hand in an orthodontic laboratory, a...
What is the current status of trial NCT05743127?
This trial is currently recruiting. It is a NA study. The enrollment target is 42 participants. The study started on 2023-02-15. Estimated completion is 2027-05-01.
What conditions does trial NCT05743127 study?
This clinical trial studies the following conditions: Maxillary Expansion.
What interventions are being tested in trial NCT05743127?
The interventions under investigation include: 3D-Printed Hyrax Expander (DEVICE), Conventional Laboratory Fabricated Hyrax Expander (DEVICE).
Who is sponsoring clinical trial NCT05743127?
This trial is sponsored by Ildeu Andrade Jr., which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05743127 being conducted?
This trial has 2 study locations across Pennsylvania, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05743127's enrollment target sits among peer trials
42 1436th of 2000 higher than 555 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI